Arbutus Biopharma (ABUS) Depreciation and Depletion (2015 - 2021)
Arbutus Biopharma (ABUS) posted Depreciation and Depletion of $474000.0 for Q4 2021, up 6.04% sequentially from $447000.0 in Q3 2021, and down 6.88% YoY from $509000.0 in Q4 2020.
Arbutus Biopharma (ABUS) Depreciation and Depletion (2015 - 2021) Analysis & Trends
Arbutus Biopharma has reported Depreciation and Depletion for 7 years, with the latest figure at $474000.0 in Q4 2021.
- Quarterly Depreciation and Depletion fell 6.88% year-over-year to $474000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.8 million (down 10.0% YoY) and the FY2025 annual result came in at $400000.0, down 71.43% from the prior year.
- Depreciation and Depletion rose to $474000.0 in Q4 2021 per ABUS's latest filing, from $447000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $620000.0 in Q4 2017 and troughed at $334000.0 in Q1 2017.
- A 5-year average of $501800.0 and a median of $502500.0 in 2018 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2017 and 2018: Depreciation and Depletion jumped 103.78% in 2017, then retreated 18.71% in 2018.
- Over 5 years, Depreciation and Depletion stood at $620000.0 in 2017, then retreated by 18.71% to $504000.0 in 2018, then rose by 0.6% to $507000.0 in 2019, then increased by 0.39% to $509000.0 in 2020, then declined by 6.88% to $474000.0 in 2021.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $474000.0, $447000.0, and $436000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 474,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Mar 31, 2021 | 443,000.00 |
| Mar 31, 2021 | 443,000.00 |
| Dec 31, 2020 | 509,000.00 |
| Dec 31, 2020 | 509,000.00 |
| Sep 30, 2020 | 490,000.00 |
| Sep 30, 2020 | 490,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 507,000.00 |
| Dec 31, 2019 | 507,000.00 |
| Sep 30, 2019 | 507,000.00 |
| Sep 30, 2019 | 507,000.00 |